Sign in

CIK 0001621227

  • Non-accelerated filer
  • Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 1235430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market buy Director bought 47,280 shares at $0.84 ($39,715)
  4. 4 Open-market sale Chief Technology Officer sold 25,000 shares at $13.79 ($344,750)
  5. 4 Open-market buy 10% owner bought 15,000,000 shares at $1.67 ($25,000,500)
  6. 4 Open-market buy 10% owner bought 15,000,000 shares at $1.67 ($25,000,500)
  7. 4 Open-market buy 10% owner bought 15,000,000 shares at $1.67 ($25,000,500)
  8. 4 Open-market buy Director bought 15,000,000 shares at $1.67 ($25,000,500)
  9. 4 Open-market buy 10% owner bought 3,000,000 shares at $1.67 ($5,000,100)
  10. 4 Open-market buy 10% owner bought 15,000,000 shares at $1.67 ($25,000,500)
  11. 4 Open-market buy Director bought 12,000,000 shares at $1.67 ($20,000,400)
  12. 4 Open-market buy 10% owner bought 15,000,000 shares at $1.67 ($25,000,500)
  13. 4 Open-market buy 10% owner bought 15,000,000 shares at $1.67 ($25,000,500)
  14. 4 Open-market buy 10% owner bought 3,000,000 shares at $1.67 ($5,000,100)
  15. 4 Open-market buy 10% owner bought 3,000,000 shares at $1.67 ($5,000,100)
  16. 4 Open-market sale Chief Technology Officer sold 25,000 shares at $10.25 ($256,250)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 12 of 18 · 351 filings